Hospira, Inc. (NYSE:HSP)

CAPS Rating: 2 out of 5

A specialty pharmaceutical and medication delivery company that is focused on products that improve the productivity, safety and efficacy of patient care.

Recs

0
Player Avatar crubenst (20.71) Submitted: 5/27/2010 11:10:01 AM : Outperform Start Price: $51.17 HSP Score: -57.33

Love their new aquisition of Javelin pharmaceuticals

Featured Broker Partners


Advertisement